Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Keytruda
Keytruda
For some lung cancer patients, Keytruda provides lasting benefit
Biopharma Dive
Sat, 06/1/19 - 12:41 pm
Merck
Keytruda
ASCO 2019
lung cancer
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Thu, 05/30/19 - 09:39 am
Merck
Keytruda
Sanofi
Regeneron
Dupixent
Alexion
Soliris
FDA
Dova Pharmaceuticals
Retrophin
Merck’s Keytruda fails in triple negative breast cancer trial
Pharmaforum
Tue, 05/21/19 - 09:41 am
Merck
Keytruda
clinical trials
triple negative breast cancer
Keytruda drives another strong Merck quarter, but what’s next?
Pharmaforum
Wed, 05/1/19 - 10:59 am
Merck
Keytruda
Gardasil
vaccines
Keytruda PhIII failure in gastric cancer blights Merck's quest for frontline dominance
Endpoints
Fri, 04/26/19 - 10:14 am
Merck
Keytruda
gastric cancer
Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer
Xconomy
Mon, 04/22/19 - 11:11 am
Merck
FDA
Keytruda
kidney cancer
advanced renal cell carcinoma
Inlyta
FDA expands Keytruda approval for first-line NSCLC treatment
Pharmaforum
Fri, 04/12/19 - 11:26 am
Merck
Keytruda
FDA
non-small cell lung cancer
AACR: One year after mammoth lung cancer win, Merck's Keytruda holds its own in tough-to-treat subgroups
Fierce Pharma
Mon, 04/1/19 - 12:36 pm
Merck
Keytruda
AACR
Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable?
Fierce Pharma
Sat, 03/30/19 - 12:02 am
Merck
Keytruda
China
advanced non-squamous non-small cell lung cancer
Will GSK/Tesaro’s Checkpoint Inhibitor Be Able to Compete With Merck’s Keytruda?
BioSpace
Wed, 03/20/19 - 12:27 pm
GSK
Tesaro
Merck
Keytruda
endometrial cancer
dostarlimab
Analysts: Keytruda has a blockbuster market not factored into Merck’s forecasts—China
Fierce Pharma
Fri, 03/15/19 - 12:20 pm
Merck
Keytruda
immuno-oncology
China
Merck notches fourth lung cancer approval in Europe for flagship Keytruda
Endpoints
Thu, 03/14/19 - 10:14 am
Merck
Keytruda
metastatic squamous non-small cell lung cancer
Europe
Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda
Yahoo/Zacks.com
Tue, 03/5/19 - 09:35 am
EMA
CHMP
Keytruda
Merck
Merck Gets Priority Review for Keytruda in Third-Line SCLC
Yahoo/Zacks.com
Thu, 02/21/19 - 10:11 am
Merck
Keytruda
advanced SCLC
Merck expands Mass. reach with Torque cancer collaboration
Bizjournals
Wed, 02/20/19 - 10:09 am
Torque
Merck
Keytruda
immuno-oncology
TRQ-1501
Keytruda gets okay from FDA for adjuvant melanoma
Pharmaforum
Wed, 02/20/19 - 09:49 am
FDA
Merck
adjuvant melanoma
melanoma
Keytruda
Merck’s PhIII liver cancer study for Keytruda fails on two key endpoints, just three months after the FDA gave it the green light
Endpoints
Tue, 02/19/19 - 07:48 pm
Merck
Keytruda
clinical trials
liver cancer
Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster
Motley Fool
Tue, 02/19/19 - 12:20 pm
Pfizer
Inlyta
kidney cancer
Merck
Keytruda
Merck, Pfizer drug combo extends kidney cancer survival -study
Yahoo/Reuters
Sun, 02/17/19 - 11:57 pm
Merck
Pfizer
kidney cancer
Keytruda
Inlyta
Sutent
Keytruda-Inlyta combo under Priority Review for first-line RCC
BioCentury
Fri, 02/15/19 - 10:34 am
Merck
Keytruda
Inlyta
renal cell carcinoma
FDA
priority review
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »